Skip to main content
Journal cover image

Risk factors for progression from Clostridioides difficile colonization (NAAT+/toxin-) to infection (toxin+) following symptomatic retesting.

Publication ,  Journal Article
Chang, S; Turner, N; Yarrington, M; Anderson, D
Published in: Infect Control Hosp Epidemiol
December 19, 2025

OBJECTIVE: To identify host and clinical risk factors contributing to the development of Clostridioides difficile infection (CDI) among colonized patients. DESIGN: Retrospective, matched case-control study. SETTING: Duke University Health System, including 3 hospitals and affiliated outpatient clinics. PARTICIPANTS: Adult patients who underwent ≥2 two-step C. difficile tests (nucleic acid amplification test (NAAT) followed by toxin enzyme immunoassay) between 03/15/2020-12/31/2023. Cases were patients with C. difficile colonization (NAAT+/toxin-) who converted to CDI (NAAT+/toxin+) within 90 days; controls were colonized patients who remained toxin-negative. Cases were matched to controls by date of index testing (±1 year). METHODS: Data collection encompassed a 90-day "pre-exposure" period preceding index testing and a ≤ 90-day "exposure" period between index and repeat testing. Antibiotic use was stratified by risk for each period. Multivariate conditional logistic regression with forward selection was used to identify predictors of progression. RESULTS: Among 2,212 colonized patients, 71 cases and 133 matched controls were identified. Several host and clinical characteristics were independently associated with progression to CDI in our multivariate model. Notably, high-risk antibiotic use across the pre-exposure and exposure periods was associated with greater odds of progression to CDI compared to other patterns of antibiotic use (adjusted odds ratio 2.70; P = .03). CONCLUSIONS: Sustained exposure to high-risk antibiotics was a strong predictor of the progression from C. difficile colonization to infection, underscoring the need for further research on longitudinal stewardship strategies for CDI prevention, particularly among patients previously identified as colonized.

Duke Scholars

Published In

Infect Control Hosp Epidemiol

DOI

EISSN

1559-6834

Publication Date

December 19, 2025

Start / End Page

1 / 7

Location

United States

Related Subject Headings

  • Epidemiology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chang, S., Turner, N., Yarrington, M., & Anderson, D. (2025). Risk factors for progression from Clostridioides difficile colonization (NAAT+/toxin-) to infection (toxin+) following symptomatic retesting. Infect Control Hosp Epidemiol, 1–7. https://doi.org/10.1017/ice.2025.10377
Chang, Sophia, Nicholas Turner, Michael Yarrington, and Deverick Anderson. “Risk factors for progression from Clostridioides difficile colonization (NAAT+/toxin-) to infection (toxin+) following symptomatic retesting.Infect Control Hosp Epidemiol, December 19, 2025, 1–7. https://doi.org/10.1017/ice.2025.10377.
Chang S, Turner N, Yarrington M, Anderson D. Risk factors for progression from Clostridioides difficile colonization (NAAT+/toxin-) to infection (toxin+) following symptomatic retesting. Infect Control Hosp Epidemiol. 2025 Dec 19;1–7.
Chang, Sophia, et al. “Risk factors for progression from Clostridioides difficile colonization (NAAT+/toxin-) to infection (toxin+) following symptomatic retesting.Infect Control Hosp Epidemiol, Dec. 2025, pp. 1–7. Pubmed, doi:10.1017/ice.2025.10377.
Chang S, Turner N, Yarrington M, Anderson D. Risk factors for progression from Clostridioides difficile colonization (NAAT+/toxin-) to infection (toxin+) following symptomatic retesting. Infect Control Hosp Epidemiol. 2025 Dec 19;1–7.
Journal cover image

Published In

Infect Control Hosp Epidemiol

DOI

EISSN

1559-6834

Publication Date

December 19, 2025

Start / End Page

1 / 7

Location

United States

Related Subject Headings

  • Epidemiology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences